Identification of Hub Genes and Therapeutic Drugs in Osteonecrosis of the Femoral Head Through Integrated Bioinformatics Analysis and Literature Mining

Overview

Journal Sci Rep

Specialty Science

Date 2023 Jul 24

PMID 37488209

Authors

Lan Tang

Bin Li

Qiuming Su

Xi Chen

Rongxin He

Affiliations

Soon will be listed here.

Abstract

Osteonecrosis of the femoral head (ONFH) is a multifactorial disease leading to severely limited function. By far, the etiology and pathogenesis of ONFH are not fully understood, and surgery is the only effective way to treat ONFH. This study aims to identify hub genes and therapeutic drugs in ONFH. Two gene expression profiles were downloaded from the gene expression omnibus database, and the hub genes and candidate drugs for ONFH were identified through integrated bioinformatics analysis and cross-validated by literature mining. A total of 159 DEGs were identified. PTGS2, LRRK2, ANXA5, IGF1R, MCL1, TIMP2, LYN, CD68, CBL, and RUNX2 were validated as 10 hub genes, which has considerable implications for future genetic research and related research fields of ONFH. Our findings indicate that 85 drugs interact with ONFH, with most drugs exhibiting a positive impact on ONFH by promoting osteogenesis and angiogenesis or inhibiting microcirculation embolism, rather than being anti-inflammatory. Our study provides novel insights into the pathogenesis, prevention, and treatment of ONFH.

References

Mont M, Salem H, Piuzzi N, Goodman S, Jones L . Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A 5-Year Update. J Bone Joint Surg Am. 2020; 102(12):1084-1099. PMC: 7508290. DOI: 10.2106/JBJS.19.01271. View

Komiyama T, Nishida K, Yorimitsu M, Doi H, Miyazawa S, Kitamura A . Decreased levels of insulin-like growth factor-1 and vascular endothelial growth factor relevant to the ossification disturbance in femoral heads spontaneous hypertensive rats. Acta Med Okayama. 2006; 60(3):141-8. DOI: 10.18926/AMO/30749. View

Sun L, Blair H, Peng Y, Zaidi N, Adebanjo O, Wu X . Calcineurin regulates bone formation by the osteoblast. Proc Natl Acad Sci U S A. 2005; 102(47):17130-5. PMC: 1288002. DOI: 10.1073/pnas.0508480102. View

Hedri H, Cherif M, Zouaghi K, Abderrahim E, Goucha R, Ben Hamida F . Avascular osteonecrosis after renal transplantation. Transplant Proc. 2007; 39(4):1036-8. DOI: 10.1016/j.transproceed.2007.02.031. View

Wang A, Ren M, Wang J . The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature. Gene. 2018; 671:103-109. DOI: 10.1016/j.gene.2018.05.091. View

Rezus E, Tamba B, Badescu M, Popescu D, Bratoiu I, Rezus C . Osteonecrosis of the Femoral Head in Patients with Hypercoagulability-From Pathophysiology to Therapeutic Implications. Int J Mol Sci. 2021; 22(13). PMC: 8268880. DOI: 10.3390/ijms22136801. View

Wang C, Wang F, Yang K, Huang C, Lee M, Chan Y . Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate. Arch Orthop Trauma Surg. 2007; 128(9):901-8. DOI: 10.1007/s00402-007-0530-5. View

Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H . Does alendronate prevent collapse in osteonecrosis of the femoral head?. Clin Orthop Relat Res. 2006; 443:273-9. DOI: 10.1097/01.blo.0000194078.32776.31. View

Tai T, Chen C, Su F, Tu Y, Tsai T, Lin C . Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells. Sci Rep. 2017; 7:44245. PMC: 5345019. DOI: 10.1038/srep44245. View

10.

Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C . Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians. Ann Intern Med. 2023; 176(2):182-195. DOI: 10.7326/M22-0684. View

11.

Tong S, Yin J, Liu J . Platelet-rich plasma has beneficial effects in mice with osteonecrosis of the femoral head by promoting angiogenesis. Exp Ther Med. 2018; 15(2):1781-1788. PMC: 5776555. DOI: 10.3892/etm.2017.5655. View

12.

Rabquer B, Tan G, Shaheen P, Haines 3rd G, Urquhart A, Koch A . Synovial inflammation in patients with osteonecrosis of the femoral head. Clin Transl Sci. 2010; 2(4):273-8. PMC: 2925228. DOI: 10.1111/j.1752-8062.2009.00133.x. View

13.

Fromigue O, Hay E, Barbara A, Marie P . Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate. J Biol Chem. 2010; 285(33):25251-8. PMC: 2919088. DOI: 10.1074/jbc.M110.110502. View

14.

Rodriques S, Stickels R, Goeva A, Martin C, Murray E, Vanderburg C . Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution. Science. 2019; 363(6434):1463-1467. PMC: 6927209. DOI: 10.1126/science.aaw1219. View

15.

Seleznick M, Silveira L, Espinoza L . Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol. 1991; 18(9):1416-7. View

16.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

17.

Pathan M, Keerthikumar S, Ang C, Gangoda L, Quek C, Williamson N . FunRich: An open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015; 15(15):2597-601. DOI: 10.1002/pmic.201400515. View

18.

Liebergall M, Floman Y, Milgrom C . NSAID induced avascular necrosis and arthropathy of femoral head. Orthop Rev. 1987; 16(9):652-3. View

19.

Surazynski A, Jarzabek K, Haczynski J, Laudanski P, Palka J, Wolczynski S . Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. Int J Mol Med. 2003; 12(5):803-9. View

20.

Kawahara M, Kuroshima S, Sawase T . Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Int J Implant Dent. 2021; 7(1):47. PMC: 8119587. DOI: 10.1186/s40729-021-00323-0. View